Your browser is no longer supported. Please, upgrade your browser.
Settings
FREQ [NASD]
Frequency Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.25 Insider Own2.20% Shs Outstand34.12M Perf Week3.48%
Market Cap264.27M Forward P/E- EPS next Y-1.94 Insider Trans-9.46% Shs Float27.89M Perf Month-13.19%
Income-42.00M PEG- EPS next Q-0.51 Inst Own60.10% Short Float20.49% Perf Quarter-27.72%
Sales34.40M P/S7.68 EPS this Y-29.30% Inst Trans2.18% Short Ratio12.19 Perf Half Y-82.04%
Book/sh5.20 P/B1.54 EPS next Y-27.80% ROA-17.80% Target Price- Perf Year-62.02%
Cash/sh5.92 P/C1.36 EPS next 5Y- ROE-23.00% 52W Range7.34 - 58.37 Perf YTD-77.23%
Dividend- P/FCF- EPS past 5Y- ROI-13.30% 52W High-85.88% Beta-
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin- 52W Low12.34% ATR0.51
Employees83 Current Ratio10.60 Sales Q/Q-35.60% Oper. Margin- RSI (14)45.34 Volatility6.27% 6.04%
OptionableYes Debt/Eq0.08 EPS Q/Q-275.20% Profit Margin- Rel Volume0.25 Prev Close8.03
ShortableYes LT Debt/Eq0.08 Earnings- Payout- Avg Volume468.94K Price8.24
Recom2.20 SMA20-0.56% SMA50-8.44% SMA200-64.57% Volume58,034 Change2.62%
Jan-27-21Upgrade JP Morgan Neutral → Overweight $56
Dec-22-20Initiated B. Riley Securities Buy $79
Jul-14-20Initiated Oppenheimer Outperform $36
May-18-20Downgrade JP Morgan Overweight → Neutral $27
Oct-28-19Initiated JP Morgan Overweight $25
Oct-28-19Initiated Goldman Buy $30
Oct-28-19Initiated Cowen Outperform
Aug-02-21 03:05PM  
02:30PM  
12:30PM  
12:30PM  
11:00AM  
10:00AM  
09:16AM  
09:09AM  
05:50AM  
03:27AM  
Aug-01-21 10:38AM  
06:36AM  
Jul-30-21 08:49PM  
07:19PM  
07:10PM  
05:15PM  
02:57PM  
01:30PM  
12:40PM  
11:30AM  
11:30AM  
11:00AM  
10:00AM  
10:00AM  
09:30AM  
09:00AM  
05:18AM  
Jul-29-21 08:47PM  
05:29PM  
04:02PM  
01:15PM  
12:30PM  
10:45AM  
10:00AM  
09:24AM  
05:27AM  
Jul-28-21 08:00PM  
07:25PM  
07:07PM  
05:34PM  
03:16PM  
01:45PM  
01:35PM  
01:15PM  
12:30PM  
11:00AM  
10:00AM  
09:33AM  
09:30AM  
09:07AM  
Jul-27-21 06:24PM  
05:32PM  
12:45PM  
11:15AM  
11:14AM  
10:40AM  
09:49AM  
09:00AM  
05:40AM  
12:50AM  
Jul-26-21 09:45PM  
08:10PM  
06:58PM  
05:28PM  
03:48PM  
03:23PM  
02:12PM  
01:55PM  
01:00PM  
12:10PM  
11:13AM  
09:45AM  
09:15AM  
09:08AM  
05:40AM  
12:10AM  
Jul-25-21 11:00AM  
11:00AM  
10:34AM  
Jul-24-21 08:35PM  
Jul-23-21 08:43PM  
08:32PM  
03:00PM  
01:30PM  
11:40AM  
10:53AM  
09:30AM  
09:19AM  
09:15AM  
09:00AM  
Jul-22-21 09:00PM  
08:30PM  
12:37PM  
11:00AM  
10:45AM  
09:33AM  
09:18AM  
05:24AM  
Jul-21-21 09:30PM  
08:29PM  
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, Mass General Brigham, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucchino David L.President and CEOJul 01Option Exercise0.616,9054,212428,681Jul 06 04:22 PM
Lucchino David L.President and CEOJun 21Option Exercise0.61113,69069,351421,776Jun 23 08:31 AM
McCubbin QuentinChief Manufacturing OfficerMay 17Buy8.8510,00088,50010,000May 19 04:04 PM
MARCUS JOEL SDirectorMar 25Option Exercise3.3737,116125,081307,116Mar 29 04:37 PM
Lucchino David L.President and CEOMar 01Option Exercise0.619,4165,744317,502Mar 02 08:01 PM
Lucchino David L.President and CEOMar 01Sale50.439,416474,836308,086Mar 02 08:01 PM
Lucchino David L.President and CEOFeb 08Option Exercise0.6116,55410,098324,640Feb 10 04:55 PM
Lucchino David L.President and CEOFeb 08Sale55.0016,554910,470308,086Feb 10 04:55 PM
Lucchino David L.President and CEOFeb 03Option Exercise0.6111,0366,732319,122Feb 05 07:44 AM
Loose Christopher R.Chief Scientific OfficerFeb 03Sale47.192,00094,38021,782Feb 03 05:58 PM
Lucchino David L.President and CEOFeb 03Sale48.7511,036538,005308,086Feb 05 07:44 AM
Lucchino David L.President and CEOFeb 02Option Exercise0.615,5183,366313,604Feb 04 05:44 PM
Lucchino David L.President and CEOFeb 02Sale46.105,518254,360308,086Feb 04 05:44 PM
Loose Christopher R.Chief Scientific OfficerFeb 02Sale45.028,000360,19623,782Feb 03 05:58 PM
Lucchino David L.President and CEOFeb 01Option Exercise0.6133,10220,192341,188Feb 03 06:05 PM
Lucchino David L.President and CEOFeb 01Sale43.0933,1021,426,370308,086Feb 03 06:05 PM
Lucchino David L.President and CEOJan 27Option Exercise0.619,1965,610317,282Jan 28 05:27 PM
Lucchino David L.President and CEOJan 27Sale42.509,196390,830308,086Jan 28 05:27 PM
Loose Christopher R.Chief Scientific OfficerJan 27Sale42.508,000340,00031,782Jan 28 05:24 PM
Lucchino David L.President and CEOJan 06Option Exercise0.6127,58616,827335,672Jan 08 07:08 AM
Lucchino David L.President and CEOJan 06Sale38.5727,5861,063,917308,086Jan 08 07:08 AM
Lucchino David L.President and CEOJan 04Option Exercise0.6118,39011,218342,190Jan 06 04:53 PM
Lucchino David L.President and CEOJan 04Sale33.2134,1041,132,740308,086Jan 06 04:53 PM
MARCUS JOEL SDirectorDec 22Sale33.6120,000672,134270,000Dec 22 06:41 PM
MARCUS JOEL SDirectorDec 21Sale30.3510,000303,521290,000Dec 22 06:41 PM
MARCUS JOEL SDirectorDec 18Sale36.8919,700726,757300,000Dec 22 06:41 PM
Lucchino David L.President and CEODec 17Option Exercise0.611,120683324,920Dec 21 04:51 PM
Lucchino David L.President and CEODec 17Sale42.641,12047,755323,800Dec 21 04:51 PM
Loose Christopher R.Chief Scientific OfficerDec 17Sale40.638,000325,00139,782Dec 17 08:13 PM
Lucchino David L.President and CEODec 16Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 16Sale38.948,000311,48047,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 16Sale40.0013,514540,560323,800Dec 16 08:01 PM
Lucchino David L.President and CEODec 15Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 15Sale37.288,000298,24055,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 15Sale38.4013,514518,890323,800Dec 16 08:01 PM
Lucchino David L.President and CEODec 14Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Lucchino David L.President and CEODec 14Sale35.1213,514474,612323,800Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 14Sale35.008,000280,00063,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 09Option Exercise0.6113,5148,244337,314Dec 10 05:25 PM
Lucchino David L.President and CEODec 09Sale32.9313,514444,984323,800Dec 10 05:25 PM
Lucchino David L.President and CEODec 08Option Exercise0.618,8485,397332,648Dec 09 05:21 PM
Lucchino David L.President and CEODec 08Sale31.268,848276,621323,800Dec 09 05:21 PM
Lucchino David L.President and CEODec 07Option Exercise0.614,6662,846328,466Dec 09 05:21 PM
Lucchino David L.President and CEODec 07Sale30.024,666140,065323,800Dec 09 05:21 PM
Lucchino David L.President and CEODec 01Sale27.9315,714438,871323,800Dec 03 04:40 PM
Loose Christopher R.Chief Scientific OfficerNov 09Sale24.008,000192,00071,782Nov 09 04:34 PM
Loose Christopher R.Chief Scientific OfficerNov 05Sale23.008,000184,00079,782Nov 09 04:34 PM
Lucchino David L.President and CEONov 02Sale20.8115,714326,972339,514Nov 03 06:57 PM
Loose Christopher R.Chief Scientific OfficerOct 13Sale22.008,000176,00087,782Oct 14 04:29 PM
Loose Christopher R.Chief Scientific OfficerOct 08Sale21.128,000168,96095,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 07Sale20.008,000160,010103,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 06Sale19.468,000155,680111,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 05Sale18.358,000146,800119,782Oct 05 05:14 PM
Loose Christopher R.Chief Scientific OfficerOct 02Sale18.928,000151,360127,782Oct 05 05:14 PM
Lucchino David L.President and CEOOct 01Sale19.1315,716300,658355,228Oct 05 04:26 PM
Loose Christopher R.Chief Scientific OfficerOct 01Sale18.848,000150,720135,782Oct 05 05:14 PM
Loose Christopher R.Chief Scientific OfficerSep 23Sale21.134,50095,097143,782Sep 25 08:55 AM
Loose Christopher R.Chief Scientific OfficerSep 09Sale18.974,50085,369148,282Sep 10 04:56 PM
Lucchino David L.President and CEOSep 01Sale18.5515,714291,474370,944Sep 03 04:16 PM
Loose Christopher R.Chief Scientific OfficerAug 19Sale22.974,500103,350152,782Aug 20 04:29 PM
Loose Christopher R.Chief Scientific OfficerAug 05Sale21.214,50095,464157,282Aug 06 05:15 PM